|
| | tripterifordin Basic information |
| Product Name: | tripterifordin | | Synonyms: | tripterifordin;Hypodiolide A;TRIPTERIFORDIN; HYPODIOLIDE A;Antriptolactone;Hydroxyodolide;Kauran-18-oic acid, 16,20-dihydroxy-, δ-lactone, (4α)-;ripterifordin;(4S,4aS,6aS,8R,9R,11aS,11bR)-8-hydroxy-4,8-dimethyldodecahydro-1H-6a,9-methano-4,11b-(methanooxymethano)cyclohepta[a]naphthalen-14-one | | CAS: | 139122-81-9 | | MF: | C20H30O3 | | MW: | 318.45 | | EINECS: | | | Product Categories: | Diterpenoids | | Mol File: | 139122-81-9.mol |  |
| | tripterifordin Chemical Properties |
| Boiling point | 485.1±45.0 °C(Predicted) | | density | 1.19±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | Powder | | pka | 15.24±0.40(Predicted) |
| | tripterifordin Usage And Synthesis |
| Definition | ChEBI: A kaurane diterpenoid that is (5beta,8alpha,13alpha)-18,20-epoxykauran-18-one substituted by a hydroxy group at position 16. Isolated from the roots of Tripterygium wilfordii, it exhibits anti
HIV activity. | | target | HIV | Immunology & Inflammation related |
| | tripterifordin Preparation Products And Raw materials |
|
